Ernexa Therapeutics (ERNA) Asset Utilization Ratio (2016 - 2025)
Historic Asset Utilization Ratio for Ernexa Therapeutics (ERNA) over the last 15 years, with Q3 2025 value amounting to 0.0.
- Ernexa Therapeutics' Asset Utilization Ratio fell 8811.63% to 0.0 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.0, marking a year-over-year decrease of 8811.63%. This contributed to the annual value of 0.02 for FY2024, which is 68760.68% up from last year.
- Per Ernexa Therapeutics' latest filing, its Asset Utilization Ratio stood at 0.0 for Q3 2025, which was down 8811.63% from 0.08 recorded in Q2 2025.
- Ernexa Therapeutics' 5-year Asset Utilization Ratio high stood at 0.2 for Q1 2021, and its period low was 0.01 during Q2 2023.
- For the 5-year period, Ernexa Therapeutics' Asset Utilization Ratio averaged around 0.03, with its median value being 0.0 (2025).
- As far as peak fluctuations go, Ernexa Therapeutics' Asset Utilization Ratio tumbled by 173493.56% in 2023, and later skyrocketed by 495278.44% in 2025.
- Over the past 5 years, Ernexa Therapeutics' Asset Utilization Ratio (Quarter) stood at 0.02 in 2021, then plummeted by 102.87% to 0.0 in 2022, then plummeted by 374.87% to 0.0 in 2023, then skyrocketed by 3102.41% to 0.09 in 2024, then plummeted by 97.01% to 0.0 in 2025.
- Its last three reported values are 0.0 in Q3 2025, 0.08 for Q2 2025, and 0.11 during Q1 2025.